NTRK fusions, which result from rearrangements in the NTRK1, NTRK2, or NTRK3 genes (encoding TRKA, TRKB, and TRKC, respectively), are actionable oncogenic drivers found in a diverse range of adult and pediatric cancers. The gene discussed is NTRK2; the disease is cancer.